Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The BEAN1 gene encodes a protein associated with NEDD4, a ubiquitin-protein ligase. It is implicated in spinocerebellar ataxia type 31 and has been linked to poor prognosis and treatment resistance in cancer, particularly through its role in extracellular matrix remodeling and signaling pathways like Wnt and TGF-β[1][4][5].
Not well-defined for drugs targeting BEAN1, but it may involve modulation of signaling pathways like Wnt/β-catenin and TGF-β.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Brain-expressed protein associating with Nedd4 homolog (BEAN1).